Proteostasis Therapeutics , which is developing combination therapeutics that use amplifier molecules to modulate proteins, announced ...
Read More
Home / Cystic fibrosis biotech Proteostasis Therapeutics sets terms for $50 million IPO
Showing posts with label Cystic fibrosis biotech Proteostasis Therapeutics sets terms for $50 million IPO. Show all posts
Showing posts with label Cystic fibrosis biotech Proteostasis Therapeutics sets terms for $50 million IPO. Show all posts
Subscribe to:
Posts
(
Atom
)